Following the successful conjugation of anti-NTSR1-mAb to the surface of the hybrid nanoparticles, it was essential to confirm the involvement of NTSR1 in the uptake of these nanoparticles by lung adenocarcinoma cells known to overexpress this receptor. The gene discussed is NTSR1; the disease is lung adenocarcinoma.